Skip to main content
Download PDF

Volume 16 Supplement 2

3rd International Clinical Trials Methodology Conference

Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks

Trials volume 16, Article number: O14 (2015) Cite this article

Background

No randomised controlled trial has been successfully conducted during an influenza pandemic. The ASAP trial (Adjuvant Steroids in Adults with Pandemic Influenza) aims to use the novel strategy of set-up in advance of an influenza pandemic, and ‘hibernation’ in readiness for activation in a pandemic. Upon activation, the trial needs to recruit the first participant within 4 weeks, and to complete recruitment of 2200 participants within the first pandemic wave of approximately 6 weeks.

Methods

Approvals are in place for 40 sites being maintained in ‘hibernation’. Three key programmes of work during hibernation have been identified: 1) Regular review to ensure compliance with current regulations, viability of Investigational Medicinal Product (IMP) and appropriate trial materials, 2) Planning for the ‘pre-activation’ phase (time between trial activation and first participant recruited), 3) Clinical Trials Unit (CTU) planning for activation.

Results

Regular review includes detailed annual checks of trial site readiness and interest, review of trial materials and contracts, replacement of expiring IMP, maintenance of trial oversight committees and reporting to stakeholders. Planning for pre-activation includes packaging of IMP, developing of training materials, and logistical aspects of trial delivery including changes in key trial staff. The CTU is also developing an operational plan to support activation and reporting.

Discussion

Long term maintenance of a clinical trial in readiness for a public health emergency is extremely challenging. Careful planning and detailed procedures should enable rapid activation and delivery of this trial. Anticipating future uncertainties is a key facet of trial maintenance during hibernation.

Author information

Affiliations

  1. Nottingham Clinical Trials Unit, Nottingham, UK

    Clare Brittain, Garry Meakin, Margo Childs & Lelia Duley

  2. Nottingham University Hospitals NHS Trust, Nottingham, UK

    Wei Shen Lim

Authors
  1. Clare Brittain
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Garry Meakin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Margo Childs
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lelia Duley
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Wei Shen Lim
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Clare Brittain.

Rights and permissions

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Brittain, C., Meakin, G., Childs, M. et al. Conducting a randomised trial during an influenza pandemic: an example of a trial set up and ‘hibernated’ ready to activate and recruit within 4 weeks. Trials 16, O14 (2015). https://doi.org/10.1186/1745-6215-16-S2-O14

Download citation

Keywords

  • Influenza
  • Influenza Pandemic
  • Public Health Emergency
  • Logistical Aspect
  • Clinical Trial Unit

Trials

ISSN: 1745-6215